These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21512172)

  • 1. Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.
    Berny-Lang MA; Hurst S; Tucker EI; Pelc LA; Wang RK; Hurn PD; Di Cera E; McCarty OJ; Gruber A
    Stroke; 2011 Jun; 42(6):1736-41. PubMed ID: 21512172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.
    Wang Y; Zhang Z; Chow N; Davis TP; Griffin JH; Chopp M; Zlokovic BV
    Stroke; 2012 Sep; 43(9):2444-9. PubMed ID: 22811462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
    Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
    Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
    Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
    Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.
    Goebel S; Li Z; Vogelmann J; Holthoff HP; Degen H; Hermann DM; Gawaz M; Ungerer M; Münch G
    PLoS One; 2013; 8(7):e66960. PubMed ID: 23935828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice.
    Kilic E; Hermann DM; Hossmann KA
    Neuroreport; 1999 Jan; 10(1):107-11. PubMed ID: 10094143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis.
    Orset C; Haelewyn B; Allan SM; Ansar S; Campos F; Cho TH; Durand A; El Amki M; Fatar M; Garcia-Yébenes I; Gauberti M; Grudzenski S; Lizasoain I; Lo E; Macrez R; Margaill I; Maysami S; Meairs S; Nighoghossian N; Orbe J; Paramo JA; Parienti JJ; Rothwell NJ; Rubio M; Waeber C; Young AR; Touzé E; Vivien D
    Stroke; 2016 May; 47(5):1312-1318. PubMed ID: 27032444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
    Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke.
    Wang D; Saleem S; Sullivan RD; Zhao T; Reed GL
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.
    Sakurama T; Kitamura R; Kaneko M
    Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke.
    Hoda MN; Siddiqui S; Herberg S; Periyasamy-Thandavan S; Bhatia K; Hafez SS; Johnson MH; Hill WD; Ergul A; Fagan SC; Hess DC
    Stroke; 2012 Oct; 43(10):2794-9. PubMed ID: 22910893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
    Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
    Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R; Xiao AY; Liu S; Wang M; Li G
    Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
    Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
    Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.